News

Read the latest ideas, insights and observations on the Australian Medicinal Cannabis Industry from the team at FreshLeaf Analytics.

Medicinal Cannabis Patient, Product and Pricing Analysis released

Australia’s Most Comprehensive Medicinal Cannabis Patient, Product and Pricing Analysis released FreshLeaf Analytics has released Australia’s most comprehensive medicinal cannabis Patient, Product and Pricing Analysis. The study was conducted in Q3 2019 and includes insights into the pricing and availability of legal medicinal cannabis products in the Australian marketplace including: Number of products in market...
Read More

First Australian Medicinal Cannabis Product hits the market

The last 2 years have seen a huge amount of speculation in Australia around medicinal cannabis stocks. A number of companies have listed on the ASX, raising substantial amounts of capital and seeing their market caps rise to astronomical levels. Auscann, one of the early movers in the medicinal cannabis game that traces its roots...
Read More

The myth of high-cost medical cannabis in Australia

Australian media has in recent years reported on the high costs of medicinal cannabis (also known as medicinal marijuana), quoting numbers as high as $40K per year for patient treatment. But does it actually cost this much? In most cases the numbers quoted are referencing patients with epilepsy who are taking extremely high dosages. Numerous...
Read More

Pricing Report

FreshLeaf Analytics, in collaboration with Cannabis Access Clinics has released Australia’s first pricing analysis for legal medicinal cannabis The study was conducted in Q3 2018 and includes insights into the pricing and availability of legal medicinal cannabis products in the Australian marketplace including:  – The number of products available to doctors has increased more than...
Read More

Leave us your info

and we will get back to you.